Menu
Live News EQUITY M impact

ALPS Partners Axiocell

Alps Group is rolling out an internal patient-derived organoid program for personalized cancer treatment in partnership with Dr. Kong Wai Mun of Axiocell Biotech

ALPS

Reported Earlier: Alps Group Rolling Out Internal Patient-Derived Organoid Program For Personalized Cancer Treatment In Partnership With Dr.

Kong Wai Mun Of Axiocell Biotech